Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Egorin

Showing results (101-110 of 159) with videos related to

Pageof 16
Sort By:
Cancer Chemotherapy and Pharmacology|June 8, 2001
Plasma and cerebrospinal fluid pharmacokinetics of gemcitabine after intravenous administration in nonhuman primatesJ Z Kerr, S L Berg, R Dauser, et al.
Cancer Research|July 1, 1983
Murine metabolism and disposition of iron:adriamycin complexesM J Egorin, R E Clawson, L A Ross, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
The effect of increasing topotecan infusion from 30 minutes to 4 hours on the duration of exposure in cerebrospinal fluidW C Zamboni, D I Lüftner, M J Egorin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
5-Fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic studyE E Vokes, J A Moormeier, M J Ratain, et al.
Cancer Research|March 1, 1986
Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicitiesM J Egorin, D A Van Echo, M Y Whitacre, et al.
Pharmacotherapy|October 18, 2000
Pharmacokinetics of gemcitabine and 2',2'-difluorodeoxyuridine in a patient with ascitesB J Delauter, R K Ramanathan, M J Egorin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1994
Effect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley ratR W Klecker, C A Jamis-Dow, M J Egorin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Therapeutic efficacy and pharmacokinetics of vindesine and vindesine-cisplatin in previously treated patients with non-small cell lung carcinomaJ Z Fuks, M J Egorin, J Aisner, et al.
Cancer Research|November 1, 1984
Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal functionM J Egorin, D A Van Echo, S J Tipping, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Human plasma pharmacokinetics of thiotepa following administration of high-dose thiotepa and cyclophosphamideS P Ackland, K E Choi, M J Ratain, et al.
Pageof 16

Showing results (101-110 of 159) with videos related to

Sort By:
Pageof 16
Cancer Chemotherapy and Pharmacology|June 8, 2001
Plasma and cerebrospinal fluid pharmacokinetics of gemcitabine after intravenous administration in nonhuman primatesJ Z Kerr, S L Berg, R Dauser, et al.
Cancer Research|July 1, 1983
Murine metabolism and disposition of iron:adriamycin complexesM J Egorin, R E Clawson, L A Ross, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
The effect of increasing topotecan infusion from 30 minutes to 4 hours on the duration of exposure in cerebrospinal fluidW C Zamboni, D I Lüftner, M J Egorin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
5-Fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic studyE E Vokes, J A Moormeier, M J Ratain, et al.
Cancer Research|March 1, 1986
Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicitiesM J Egorin, D A Van Echo, M Y Whitacre, et al.
Pharmacotherapy|October 18, 2000
Pharmacokinetics of gemcitabine and 2',2'-difluorodeoxyuridine in a patient with ascitesB J Delauter, R K Ramanathan, M J Egorin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1994
Effect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley ratR W Klecker, C A Jamis-Dow, M J Egorin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Therapeutic efficacy and pharmacokinetics of vindesine and vindesine-cisplatin in previously treated patients with non-small cell lung carcinomaJ Z Fuks, M J Egorin, J Aisner, et al.
Cancer Research|November 1, 1984
Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal functionM J Egorin, D A Van Echo, S J Tipping, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Human plasma pharmacokinetics of thiotepa following administration of high-dose thiotepa and cyclophosphamideS P Ackland, K E Choi, M J Ratain, et al.
Pageof 16